Intensity-Modulated Radiotherapy Reduces Radiation-Induced Morbidity and Improves Health-Related Quality of Life: Results of a Nonrandomized Prospective Study Using a Standardized Follow-Up Program

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 1, 2009, Pages 1-8

  Vergeer, Marije R ^a   Doornaert, Patricia A H ^a   Rietveld, Derek H F ^a   Leemans, C René ^a   Slotman, Ben J ^a   Langendijk, Johannes A ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

IMRT; Quality of life; Xerostomia

Indexed keywords

FOLLOW-UP PROGRAMS; HEAD AND NECKS; HEAD-AND-NECK CANCERS; HEAD-AND-NECK SQUAMOUS CELL CARCINOMATA; HEALTH-RELATED QUALITY OF LIVES; IMRT; INTENSITY-MODULATED RADIATION THERAPIES; INTENSITY-MODULATED RADIOTHERAPIES; MEAN DOSE; PAROTID GLANDS; POSITIVE EFFECTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIATION THERAPY ONCOLOGY GROUPS; XEROSTOMIA;

CHEMOTHERAPY; FLUORESCENT SCREENS; PATIENT MONITORING; PHYSICAL THERAPY; RADIOTHERAPY; TELEVISION PICTURE TUBES;

THREE DIMENSIONAL;

ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PAROTID GLAND; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RADIATION SICKNESS; RISK REDUCTION; SQUAMOUS CELL CARCINOMA; SYMPTOMATOLOGY; THREE DIMENSIONAL IMAGING; XEROSTOMIA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PAROTID GLAND; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; SUBMANDIBULAR GLAND; TUMOR BURDEN; XEROSTOMIA; YOUNG ADULT;

EID: 64049086382     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.059     Document Type: Article

References (26)

1. Bjordal K., Kaasa S., and Mastekaasa A. Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 28 (1994) 847-856
2. Xia P., Fu K.K., Wong G.W., et al. Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 48 (2000) 329-337
3. Roesink J.M., Moerland M.A., Battermann J.J., et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 51 (2001) 938-946
4. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
5. Eisbruch A., Ship J.A., Dawson L.A., et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. World J Surg 27 (2003) 832-837
6. de Arruda F.F., Puri D.R., Zhung J., et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 64 (2006) 363-373
7. Chao K.S., Majhail N., Huang C.J., et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: A comparison with conventional techniques. Radiother Oncol 61 (2001) 275-280
8. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66 (2006) 981-991
9. Parliament M.B., Scrimger R.A., Anderson S.G., et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 663-673
10. Jabbari S., Kim H.M., Feng M., et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: Initial report. Int J Radiat Oncol Biol Phys 63 (2005) 725-731
11. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
12. Aaronson N.K., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
13. Bjordal K., Ahlner-Elmqvist M., Tollesson E., et al. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients. EORTC Quality of Life Study Group. Acta Oncol 33 (1994) 879-885
14. Gregoire V., Coche E., Cosnard G., et al. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 56 (2000) 135-150
15. Fogliata A., Cozzi L., Bieri S., and Bernier J. Critical appraisal of a conformal head and neck cancer irradiation avoiding electron beams and field matching. Int J Radiat Oncol Biol Phys 45 (1999) 1331-1338
16. Jellema A.P., Slotman B.J., Doornaert P., et al. Impact of radiation induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 751-760
17. Graff P., Lapeyre M., Desandes E., et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: Matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1309-1317
18. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
19. Jellema A.P., Doornaert P., Slotman B.J., et al. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 (2005) 164-171
20. Meirovitz A., Murdoch-Kinch C.A., Schipper M., et al. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66 (2006) 445-453
21. Vissink A., Burlage F.R., Spijkervet F.K., et al. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 14 (2003) 213-225
22. Levendag P.C., Teguh D.N., Voet P., et al. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: A dose-effect relationship. Radiother Oncol 85 (2007) 64-73
23. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 5 (2004) 1425-1439
24. Rosenthal D.I., Chambers M.S., Fuller C.D., et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys (May 1, 2008) [Epub ahead of print]
25. Cannon D.M., and Lee N.Y. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 70 (2008) 657-659
26. Schoenfeld G.O., Amdur R.J., Morris C.G., et al. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 71 (2008) 377-385